Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% phenytoin solution for androgenetic alopecia
IRCT20190901044666N3Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of phenytoin in androgenetic alopecia (AGA), sponsored by Iran University of Medical Sciences. Primary endpoint: Number of hairs in a specified scalp area. Started Jan 2023; status: completed.
02
Drugs
phenytoin
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20190901044666N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190901044666N3.